Regeneron Pharmaceuticals (REGN) Asset Utilization Ratio (2010 - 2026)

Regeneron Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.37 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 2.04% year-over-year to 0.37 in Q1 2026; TTM through Mar 2026 was 0.37, a 2.04% decrease from a year earlier, with the FY2025 full-year figure at 0.37, down 8.65% from the prior year.
• Asset Utilization Ratio climbed to 0.37 in Q1 2026 per REGN's latest filing, from 0.36 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.52 in Q1 2022 and bottomed at 0.21 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.38 (2025), against an average of 0.37.
• Across the five-year window, Asset Utilization Ratio slumped 68.08% in 2022 and jumped 92.45% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.21 in 2022, then soared by 92.45% to 0.4 in 2023, then retreated by 6.07% to 0.38 in 2024, then slipped by 5.92% to 0.36 in 2025, then climbed by 3.13% to 0.37 in 2026.
• Per Business Quant, the three latest REGN Asset Utilization Ratio figures stand at 0.37 (Q1 2026), 0.36 (Q4 2025), and 0.36 (Q3 2025).